The GUARDIAN Pilot Trial
Key facts
- Who runs it
- The Cleveland Clinic
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people, planned
- Started
- 27 Apr 2021
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Tight pressure management
- Routine pressure management
- Record updated
- 17 March 2026
Who can take part
- Age
- 45 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (32)Hide the full registry criteria
Who can take part
- ≥45 years old
- Scheduled for major noncardiac surgery expected to last at least 2 hours
- Having general endotracheal, neuraxial anesthesia, or the combination
- Expected to require at least overnight hospitalization
- Are designated ASA physical status 2-4 (ranging from mild systemic disease through severe systemic disease that is a constant threat to life)
- Chronically taking at least one anti-hypertensive medication
- Expected to have direct blood pressure monitoring with an arterial catheter
- Cared for by clinicians willing to follow the GUARDIAN protocol
- Subject to at least one of the following risk factors:
- History of peripheral arterial surgery
- History of coronary artery disease
- History of stroke or transient ischemic attack
- Serum creatinine >175 µmol/L (>2.0 mg/dl)
- Diabetes requiring medication
- Current smoking or 15 pack-year history of smoking tobacco
- Scheduled for major vascular surgery
- Body mass index ≥35 kg/m2
- Preoperative high-sensitivity troponin T >14 ng/L or troponin I equivalent
- B-type natriuretic protein (BNP) >80 ng/L or N-terminal B-type natriuretic protein (NT-ProBNP) >100 ng/L
Who cannot take part
- Are scheduled for carotid artery surgery
- Are scheduled for intracranial surgery
- Are scheduled for pheochromocytoma surgery
- Are scheduled for liver transplantation
- Require preoperative intravenous vasoactive medications
- Have previously participated in this trial
- Have a condition that precludes routine or tight blood pressure management such as surgeon request for relative hypotension
- Have a documented history of dementia
- Have end-stage renal disease requiring dialysis or estimated glomerular filtration rate (eGFR) <30 ml/min
- Are scheduled for partial or complete nephrectomy
- Require beach-chair positioning
- Have language, vision, or hearing impairments that may compromise cognitive assessments
- Have contraindications to norepinephrine or phenylephrine per clinician judgement
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The treatments will be: 1) norepinephrine or phenylephrine infusion to maintain intraoperative MAP ≥85 mmHg, delayed resumption of chronic antihypertensive medications, and a target ward MAP ≥80 mmHg (tight pressure management); or, 2) routine intraoperative blood pressure management and prompt resumption of chronic antihypertensive medications (routine pressure management).
The 2 groups in the trial
- Tight pressure managementTreatment being tested
Patients assigned to tight blood pressure control angiotensin converting enzyme inhibitors and angiotensin receptor blockers will not be given the morning of surgery. Other chronic antihypertensives will only be given as necessary to treat hypertension. Norepinephrine or phenylephrine infusion will be infused at a rate sufficient to maintain intraoperative MAP ≥ 85 mmHg. Resumption of chronic anti-hypertensive medications will be delayed until the third postoperative day unless deemed necessary to treat hypertension or for some other clear indication. The target for postoperative systolic arterial pressures ≥110 mmHg during the initial three postoperative days.
- Routine pressure managementOther group
ACEIs, ARBs, and/or calcium channel blockers can be given the morning of surgery if deemed appropriate by the attending anesthesiologist. Intraoperative blood pressure will be managed per clinical routine. As usual, chronic anti-hypertensive medications will be restarted shortly after surgery unless contraindicated by hypotension.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Pilot Trial
- Publications
- Record updated
- 17 March 2026